Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 3
2005 3
2006 1
2008 1
2009 1
2010 1
2011 1
2012 1
2013 1
2014 2
2016 3
2017 3
2018 1
2019 4
2021 6
2022 10
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenicity of a Third Dose of BNT162b2 Vaccine among Lung Transplant Recipients-A Prospective Cohort Study.
Shostak Y, Kramer MR, Edni O, Glusman Bendersky A, Shafran N, Bakal I, Heching M, Rosengarten D, Shitenberg D, Amor SM, Ben Zvi H, Pertzov B, Cohen H, Rotem S, Elia U, Chitlaru T, Erez N, Peysakhovich Y, D Barac Y, Shlomai A, Bar-Haim E, Shtraichman O. Shostak Y, et al. Among authors: bar haim e. Vaccines (Basel). 2023 Apr 4;11(4):799. doi: 10.3390/vaccines11040799. Vaccines (Basel). 2023. PMID: 37112711 Free PMC article.
Three-month follow-up of durability of response to the third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged 60 years and older: a prospective cohort study.
Eliakim-Raz N, Stemmer A, Leibovici-Weisman Y, Ness A, Awwad M, Ghantous N, Erez N, Bareket-Samish A, Levy-Barda A, Ben-Zvi H, Moskovits N, Bar-Haim E, Stemmer SM. Eliakim-Raz N, et al. Among authors: bar haim e. BMJ Open. 2022 Aug 2;12(8):e061584. doi: 10.1136/bmjopen-2022-061584. BMJ Open. 2022. PMID: 35918111 Free PMC article.
Immune Response to Third Dose BNT162b2 COVID-19 Vaccine Among Kidney Transplant Recipients-A Prospective Study.
Yahav D, Rahamimov R, Mashraki T, Ben-Dor N, Steinmetz T, Agur T, Zingerman B, Herman-Edelstein M, Lichtenberg S, Ben-Zvi H, Bar-Haim E, Cohen H, Rotem S, Elia U, Margalit I, Zvi BR. Yahav D, et al. Among authors: bar haim e. Transpl Int. 2022 Apr 21;35:10204. doi: 10.3389/ti.2022.10204. eCollection 2022. Transpl Int. 2022. PMID: 35529596 Free PMC article.
Prolonged Protective Immunity Induced by Mild SARS-CoV-2 Infection of K18-hACE2 Mice.
Bar-On L, Aftalion M, Makdasi E, Gur D, Alcalay R, Cohen H, Beth-Din A, Rosenfeld R, Achdout H, Bar-Haim E, Falach R, Chitlaru T, Cohen O. Bar-On L, et al. Among authors: bar haim e. Vaccines (Basel). 2022 Apr 14;10(4):613. doi: 10.3390/vaccines10040613. Vaccines (Basel). 2022. PMID: 35455362 Free PMC article.
Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses.
Milo R, Staun-Ram E, Karussis D, Karni A, Hellmann MA, Bar-Haim E, Miller A; Israeli Neuroimmunology Study Group on COVID-19 Vaccination in Multiple Sclerosis. Milo R, et al. Among authors: bar haim e. Front Immunol. 2022 Apr 1;13:868915. doi: 10.3389/fimmu.2022.868915. eCollection 2022. Front Immunol. 2022. PMID: 35432335 Free PMC article.
47 results